ASTC ASTROTECH Corp
Laboratory Analytical Instruments · Nasdaq · SEC CIK 1001907 · Fiscal year ends 06/30
Financial factors as of 2026-09-30 (2027Q1), TTM = sum of the last four quarters
Growth
TTM revenue YoY-29.5%
TTM net income YoY0.9%
TTM EPS YoY—
Revenue 3-yr CAGR-7.8%
Net income 3-yr CAGR—
Margins
Gross margin14.8%
Operating margin-1,531.0%
Net margin-1,561.1%
FCF margin-1,477.9%
EBITDA margin-1,433.7%
Returns
ROE-84.3%
ROA-67.8%
ROIC (approx.)-78.7%
Asset turnover0.04x
Leverage & solvency
Liabilities / assets21.7%
Debt / equity0.00x
Current ratio7.24x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.91x
Accruals ratio-5.8%
Payout ratio—
Capex / revenue51.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2027Q12026-09-30 | 2026Q4*2026-06-30 | 2026Q32026-03-31 | 2025Q22025-12-31 | 2025Q12025-09-30 | 2025Q4*2025-06-30 | 2025Q32025-03-31 | 2025Q22024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $274,000 | $126,000 | $343,000 | $148,000 | $297,000 | $171,000 | $534,000 | $261,000 |
| Cost of revenue | $172,000 | $171,000 | $276,000 | $140,000 | $109,000 | $146,000 | $297,000 | $106,000 |
| Gross profit | $102,000 | -$45,000 | $67,000 | $8,000 | $188,000 | $74,000 | $237,000 | $155,000 |
| R&D expense | $1.03M | $1.27M | $1.44M | $1.83M | $1.94M | $1.77M | $1.99M | $2.44M |
| SG&A expense | $2.12M | $1.93M | $2.08M | $2.08M | $1.78M | $1.23M | $2.12M | $2.04M |
| Operating income | -$3.04M | -$3.25M | -$3.45M | -$3.90M | -$3.54M | -$2.92M | -$3.87M | -$4.32M |
| Pretax income | -$2.95M | -$3.26M | -$3.77M | -$3.93M | -$3.46M | -$24.75M | -$3.63M | -$4.01M |
| Income tax | $0 | — | — | $0 | $0 | — | — | $0 |
| Net income | -$2.95M | -$3.27M | -$3.77M | -$3.93M | -$3.46M | -$2.93M | -$3.63M | -$4.01M |
| EBITDA | -$2.83M | -$3.04M | -$3.23M | -$3.68M | -$3.30M | -$2.67M | -$3.62M | -$4.08M |
| EPS (basic) | -1.46 | — | -2.25 | -2.34 | -2.07 | — | -2.18 | -2.45 |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $5.62M | $8.39M | $2.68M | — | — | $3.10M | — | — |
| Short-term investments | $2.86M | $2.95M | $3.90M | $7.04M | $11.29M | $15.11M | $18.06M | $21.53M |
| Receivables | $112,000 | $124,000 | $504,000 | $133,000 | $354,000 | $485,000 | $516,000 | $340,000 |
| Current assets | $13.44M | $15.93M | $11.33M | $14.35M | $18.19M | $21.98M | $24.57M | $28.16M |
| PP&E, net | $2.20M | $2.38M | $2.57M | $2.98M | $2.61M | $2.40M | $2.49M | $2.76M |
| Intangibles | $50,000 | $50,000 | $50,000 | $50,000 | $50,000 | $48,000 | $50,000 | — |
| Total assets | $17.77M | $20.51M | $16.17M | $19.70M | $23.24M | $26.99M | $27.49M | $31.00M |
| Current liabilities | $1.85M | $2.26M | $1.83M | $1.90M | $1.86M | $2.45M | $2.49M | $2.62M |
| Total liabilities | $3.86M | $4.33M | $4.02M | $4.18M | $4.15M | $4.89M | $2.74M | $2.91M |
| Shareholders' equity | $13.91M | $16.17M | $12.15M | $15.52M | $19.09M | $22.10M | $24.75M | $28.09M |
| Shares outstanding | 2.11M | 2.00M | 1.76M | 1.76M | 1.76M | 1.76M | 1.69M | 1.70M |
| Cash flow statement | ||||||||
| Operating cash flow | -$3.19M | -$2.29M | -$3.69M | -$3.54M | -$3.94M | -$2.36M | -$3.86M | -$3.04M |
| Capital expenditure | $26,000 | $22,000 | -$2,000 | $411,000 | $448,000 | $348,000 | -$27,000 | $319,000 |
| Free cash flow | -$3.22M | -$2.31M | -$3.68M | -$3.95M | -$4.38M | -$2.71M | -$3.83M | -$3.36M |
| Investing cash flow | -$26,000 | $993,000 | $3.30M | $4.01M | $3.52M | $2.68M | $3.59M | -$279,000 |
| Financing cash flow | $448,000 | $7.00M | -$26,000 | -$18,000 | -$36,000 | -$28,000 | -$78,000 | -$34,000 |
| Depreciation & amortization | $206,000 | $212,000 | $227,000 | $222,000 | $236,000 | $244,000 | $247,000 | $239,000 |
| Stock-based compensation | $303,000 | $181,000 | $245,000 | $190,000 | $304,000 | $201,000 | $152,000 | $261,000 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.